Acute and Subacute Oral Toxicity Evaluation of Crude Antifungal Compounds Produced by Lactobacillus Plantarum HD1 in Rats

다국어 초록 (Multilingual Abstract)

The aim of this study was to investigate the acute and subacute oral toxicity of crude antifungal compounds produced by Lactobacillus plantarum HD1 in Sprague-Dawley (SD) rats. In the acute toxicity study, the crude antifungal compounds (0.625, 1.25, 2.5, and 5.0 g/kg) did not produce mortality, significant changes in general behavior, or changes in the gross appearance of the organs. In the subacute toxicity study, the crude antifungal compounds were administered orally to rats at doses of 0, 0.5, 1.0, and 2.0 g/kg daily for 28 days. There were no test article-related deaths, abnormal clinical signs, or body weight changes. The study also showed no significant differences between the control and treated groups in hematological and serum biochemical parameters, histopathological examination, or any other findings. These results suggest that acute or subacute oral administration of crude antifungal compounds from L. plantarum HD1 is not toxic in rats.

참고문헌 (Reference)

1 이재준, "김치에서 분리한 Lactobacillus plantarum AF1의 흰쥐에 대한 반복투여독성" 한국식품영양과학회 41 (41): 612-620, 2012

2 양은주, "김치로부터 항진균 활성 Lactobacillus plantarum의 분리 및 특성 규명" 한국미생물·생명공학회 36 (36): 276-284, 2008

3 이환, "김치로부터 분리한 Lactobacillus plantarum AF1의 마우스에 대한 급성독성" 한국식품저장유통학회 19 (19): 315-321, 2012

4 Abdel-Fattah SM, "The protective effect of white ginseng against biochemical and pathological changes induced by aflatoxins in rats" 6 : 461-472, 2010

5 Huang Y, "The in vivo assessment of safety and gastrointestinal survival of an orally administered novel probiotic, Propionibacterium jensenii 702, in a male Wistar rat model" 41 : 1781-1787, 2003

6 Organization for Economic Cooperation and Development, "Test No. 420: Acute oral toxicity-fixed dose procedure. In OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects"

7 Twaij HA, "Some pharmacological, toxicological and phytochemical investigations on Centaurea phyllocephala" 9 : 299-314, 1983

8 Fedlman BV, "Schalm’s veterinary hematology" Blackwell Publishing Limited 1210-1218, 2000

9 Yang EJ, "Purification of a new antifungal compound produced by Lactobacillus plantarum AF1 isolated from kimchi" 139 : 56-63, 2010

10 Ryu EH, "Purification and characterization of antifungal compounds from Lactobacillus plantarum HD1 isolated from kimchi" 41 : 19-26, 2014

11 Shu Q, "Probiotic lactic acid bacteria(Lactobacillus acidophilus HN017, Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019)have no adverse effects on the health of mice" 9 : 831-836, 1999

12 Brul S, "Preservative agents in foods : mode of action and microbial resistance mechanisms" 50 : 1-17, 1999

13 Organization for Economic Cooperation and Development, "Preliminary draft updated test guideline 407: repeated dose 28-day oral toxicity study in rodents; updated with parameters for endocrine effects. In OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects"

14 이환, "Lactobacillus plantarum AF1이 생성한 조항진균 물질의 흰쥐에 대한 반복투여독성" 한국식품저장유통학회 20 (20): 394-403, 2013

15 손희경, "Lactobacillus plantarum AF1이 생성한 조항진균 물질의 마우스에 대한 급성독성" 한국식품영양과학회 42 (42): 892-897, 2013

16 Dalié DKD, "Lactic acid bacteria-potential for control of mould growth and mycotoxins : a review" 21 : 370-380, 2010

17 Cheong EYL, "Isolation of lactic acid bacteria with antifungal activity against the common cheese spoilage mould Penicillium commune and their potential as biopreservatives in cheese" 46 : 91-97, 2014

18 Schilter B, "Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements" 41 : 1625-1649, 2003

19 Waynforth HB, "Experimental and Surgical Technique in the Rat" Academic Press 346-, 1980

20 Kennedy GL Jr, "Estimation of acute oral toxicity in rats by determination of the approximate lethal dose rather than the LD50" 6 : 145-148, 1986

21 Raza M, "Effect of prolonged vigabatrin treatment on hematological and biochemical parameters in plasma, liver and kidney of Swiss albino mice" 70 : 135-145, 2002

22 Crowley S, "Current perspectives on antifungal lactic acid bacteria as natural biopreservatives" 33 : 93-109, 2013

23 Olson H, "Concordance of the toxicity of pharmaceuticals in humans and in animals" 32 : 56-67, 2000

24 Stiles ME, "Biopreservation by lactic acid bacteria" 70 : 331-345, 1996

25 Voulgari K, "Antifungal activity of non-starter lactic acid bacteria isolates from dairy products" 21 : 136-142, 2010

26 Levine BS., "Animal clinical pathology. In Handbook of Toxicology" CRC Press 517-537, 1995

27 Singh A, "Acute and subchronic toxicity study of calcium based Ayurvedic ‘Bhasmas’ and a ‘Pishti’ prepared from marine animals" 4 : 35-47, 2010

28 Bürger C, "Acute and subacute toxicity of the hydroalcoholic extract from Wedelia paludosa(Acmela brasiliensis)(Asteraceae)in mice" 8 : 370-373, 2005

29 Li X, "Acute and subacute toxicity of ethanol extracts from Salvia przewalskii Maxim in rodents" 131 : 110-115, 2010

30 El Hilaly J, "Acute and chronic toxicological studies of Ajuga iva in experimental animals" 91 : 43-50, 2004

31 Litchfield JT Jr, "A simplified method of evaluating dose-effect experiments" 96 : 99-113, 1949